Topical aldose reductase inhibitor.
作者信息
Coster D
出版信息
Br J Ophthalmol. 1995 Dec;79(12):1064-5. doi: 10.1136/bjo.79.12.1064.
Abstract
摘要
相似文献
1
Topical aldose reductase inhibitor.局部用醛糖还原酶抑制剂。
Br J Ophthalmol. 1995 Dec;79(12):1064-5. doi: 10.1136/bjo.79.12.1064.
2
Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.用于纠正糖尿病患者角膜内皮变化的局部醛糖还原酶抑制剂。
Br J Ophthalmol. 1995 Dec;79(12):1074-7. doi: 10.1136/bjo.79.12.1074.
3
Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.用于糖尿病性角膜上皮病变的醛糖还原酶抑制剂（CT-112）滴眼液
Am J Ophthalmol. 1988 Mar 15;105(3):233-8. doi: 10.1016/0002-9394(88)90001-3.
4
[Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
Nippon Ganka Gakkai Zasshi. 1988 Jan;92(1):151-5.
5
The effect of aldose reductase inhibitor on the corneal epithelium.醛糖还原酶抑制剂对角膜上皮的作用。
Cornea. 1993 Mar;12(2):161-2. doi: 10.1097/00003226-199303000-00012.
6
[Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].[醛糖还原酶抑制剂对实验性糖尿病角膜内皮病变的预防作用]
Nippon Ganka Gakkai Zasshi. 1987 Feb;91(2):187-93.
7
Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.醛糖还原酶抑制剂CT-112可逆转糖尿病患者角膜上皮细胞的异常形态特征并提高角膜敏感性。
Am J Ophthalmol. 1995 Mar;119(3):288-94. doi: 10.1016/s0002-9394(14)71169-9.
8
Topical hyperosmolar solutions in the reduction of corneal edema.局部高渗溶液在减轻角膜水肿中的应用
CLAO J. 1987 May-Jun;13(3):149-51.
9
Discoveries in research on diabetic keratopathy.糖尿病性角膜病变的研究发现。
Optometry. 2001 Nov;72(11):691-704.
10
Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.局部滴注醛糖还原酶抑制剂CT-112后的眼内渗透情况。
J Ocul Pharmacol. 1989 Winter;5(4):325-8. doi: 10.1089/jop.1989.5.325.
本文引用的文献
1
The effect of aldose reductase inhibitor on the corneal epithelium.醛糖还原酶抑制剂对角膜上皮的作用。
Cornea. 1993 Mar;12(2):161-2. doi: 10.1097/00003226-199303000-00012.
2
Aldose reductase and its inhibition in the control of diabetic complications.醛糖还原酶及其抑制作用在糖尿病并发症控制中的研究
Ann Clin Lab Sci. 1993 Mar-Apr;23(2):148-58.
3
Pathology of corneal endothelium in keratoconus.圆锥角膜中角膜内皮的病理学
Ophthalmologica. 1993;206(4):192-208. doi: 10.1159/000310390.
4
Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.醛糖还原酶抑制剂CT-112可逆转糖尿病患者角膜上皮细胞的异常形态特征并提高角膜敏感性。
Am J Ophthalmol. 1995 Mar;119(3):288-94. doi: 10.1016/s0002-9394(14)71169-9.
5
Corneal endothelial status 12 to 55 months after excimer laser photorefractive keratectomy.准分子激光屈光性角膜切削术后12至55个月的角膜内皮状态
Ophthalmology. 1995 Apr;102(4):544-9; discussion 548-9. doi: 10.1016/s0161-6420(95)30984-0.
6
Short-term corneal endothelial changes after photorefractive keratectomy.准分子激光原位角膜磨镶术后短期角膜内皮变化。
J Refract Corneal Surg. 1994 Mar-Apr;10(2 Suppl):S194-8.
7
Distribution of aldose reductase in ocular tissues.
Exp Eye Res. 1981 Aug;33(2):175-82. doi: 10.1016/s0014-4835(81)80066-8.
8
Immunohistochemical localization of aldose reductase. II. Rat eye and kidney.醛糖还原酶的免疫组织化学定位。II. 大鼠眼睛和肾脏。
Diabetes. 1980 Jun;29(6):450-9. doi: 10.2337/diab.29.6.450.
9
Corneal endothelial changes in type I and type II diabetes mellitus.I型和II型糖尿病患者的角膜内皮变化
Am J Ophthalmol. 1984 Oct 15;98(4):401-10. doi: 10.1016/0002-9394(84)90120-x.
10
Localization of aldose reductase in the human eye.醛糖还原酶在人眼中的定位。
Diabetes. 1984 Jun;33(6):562-6. doi: 10.2337/diab.33.6.562.
Zotero 插件